Discover more insights into Human Angiotensin Converting

Human Angiotensin Converting sentence examples within receptor binding domain



Single-domain antibodies make a difference



COVID-19: Myths and Reality


Human Angiotensin Converting sentence examples within severe acute respiratory



Targeting highly pathogenic coronavirus-induced apoptosis reduces viral pathogenesis and disease severity



COVID-19 and cardiac health: A review


Human Angiotensin Converting sentence examples within 2 spike protein



Combination and tricombination therapy to destabilize the structural integrity of COVID-19 by some bioactive compounds with antiviral drugs: insights from molecular docking study



Inhibitory efficiency of potential drugs against SARS-CoV-2 by blocking human angiotensin converting enzyme-2: Virtual screening and molecular dynamics study



Learn more from Human Angiotensin Converting


Human Angiotensin Converting sentence examples within spike receptor binding



1,2,3,4,6-Pentagalloyl Glucose, a RBD-ACE2 Binding Inhibitor to Prevent SARS-CoV-2 Infection



Kobophenol A Inhibits Binding of Host ACE2 Receptor with Spike RBD Domain of SARS-CoV-2, a Lead Compound for Blocking COVID-19


Human Angiotensin Converting sentence examples within enzyme 2 receptor



Pomegranate Peel Extract as an Inhibitor of SARS-CoV-2 Spike Binding to Human ACE2 Receptor (in vitro): A Promising Source of Novel Antiviral Drugs



Antiviral drugs prioritization for COVID-19 management based on rational selection


Human Angiotensin Converting sentence examples within transgenic mice expressing



Viral neuroinvasion and neurotropism without neuronal damage in the hACE2 mouse model of COVID-19



SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target


Human Angiotensin Converting sentence examples within viral spike protein



Structural Dissection of Viral Spike-Protein Binding of SARS-CoV-2 and SARS-CoV-1 to the Human Angiotensin-Converting Enzyme 2 (ACE2) as Cellular Receptor



Computational insights into binding mechanism of drugs as potential inhibitors against SARS-CoV-2 targets


Human Angiotensin Converting sentence examples within 2 receptor binding



Insights of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) pandemic: a current review



Structure, interface stability and hot-spots identification for RBD(SARS-CoV-2):hACE2 complex formation


Human Angiotensin Converting sentence examples within human transmembrane protease



Battling against the Coronavirus Disease 2019



Membrane-Mediated Sars-cov-2 Host Cell Entry: Potential Inhibitory Roles of Terpenoids in Silico


Human Angiotensin Converting sentence examples within coronavirus disease 2019



COVID-19 In a Constrictive Pericarditis And Psychological Impact



Quinoline and Quinazoline Alkaloids against COVID-19: An In Silico Multitarget Approach


Human Angiotensin Converting sentence examples within 2 main protease



Design and synthesis of heterocyclic azole based bioactive compounds: Molecular structures, quantum simulation, and mechanistic studies through docking as multi-target inhibitors of SARS-CoV-2 and cytotoxicity



Non-competitive interactions between hydroxychloroquine and azithromycin: Systematic density functional, molecular dynamics, and docking calculations


Human Angiotensin Converting sentence examples within transmembrane protease serine



222-OR: High Glucose Level Increases Expression of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Receptors



Mechanics Insights of Alpha-Lipoic Acid against Cardiovascular Diseases during COVID-19 Infection


Human Angiotensin Converting sentence examples within spike protein receptor



A glycan gate controls opening of the SARS-CoV-2 spike protein



A Bifluorescent-Based Assay for the Identification of Neutralizing Antibodies against SARS-CoV-2 Variants of Concern In Vitro and In Vivo



Telaprevir is a potential drug for repurposing against SARS-CoV-2: computational and in vitro studies



SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice



A surrogate virus neutralization test to quantify antibody-mediated inhibition of SARS-CoV-2 in finger stick dried blood spot samples



An easy method for developing fusion enabled SARS-CoV2 virus fusion mimic (SCFM), bypassing the need of Bio Safety Level (BSL) facility.



Inhalable nanocatchers for SARS-CoV-2 inhibition



Viral neuroinvasion and neurotropism without neuronal damage in the hACE2 mouse model of COVID-19



ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19



Biophysical properties of the isolated spike protein binding helix of human ACE2



An Analysis Based on Molecular Docking and Molecular Dynamics Simulation Study of Bromelain as Anti-SARS-CoV-2 Variants



Multivalent Display of SARS-CoV-2 Spike (RBD Domain) of COVID-19 to Nanomaterial, Protein Ferritin Nanocages



Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 Receptor



Single-domain antibodies make a difference



Repurposing of anticancer phytochemicals for identifying potential fusion inhibitor for SARS-CoV-2 using molecular docking and molecular dynamics (MD) simulations.



Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2



Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike



Targeting highly pathogenic coronavirus-induced apoptosis reduces viral pathogenesis and disease severity



Molecular evolution and structural analyses of the spike glycoprotein from Brazilian SARS-CoV-2 genomes: the impact of the fixation of selected mutations



COVID-19 In a Constrictive Pericarditis And Psychological Impact



A novel pseudovirus‐based mouse model of SARS-CoV-2 infection to test COVID-19 interventions



COVID-19 and cardiac health: A review



Comparison of SARS-CoV-2 variant lethality in human angiotensin-converting enzyme 2 transgenic mice



Design and synthesis of heterocyclic azole based bioactive compounds: Molecular structures, quantum simulation, and mechanistic studies through docking as multi-target inhibitors of SARS-CoV-2 and cytotoxicity



Identification of Hotspot Residues in Binding of SARS-CoV-2 Spike and Human ACE2 Proteins



COVID-19: Myths and Reality



Combination and tricombination therapy to destabilize the structural integrity of COVID-19 by some bioactive compounds with antiviral drugs: insights from molecular docking study



1,2,3,4,6-Pentagalloyl Glucose, a RBD-ACE2 Binding Inhibitor to Prevent SARS-CoV-2 Infection



Interactions of the Receptor Binding Domain of SARS-CoV-2 Variants with hACE2: Insights from Molecular Docking Analysis and Molecular Dynamic Simulation



Marine Sulfated Polysaccharides as Promising Antiviral Agents: A Comprehensive Report and Modeling Study Focusing on SARS CoV-2



Mutation N501Y in RBD of Spike Protein Strengthens the Interaction between COVID-19 and its Receptor ACE2



Rapid Detection and Inhibition of SARS-CoV-2-Spike Mutation-Mediated Microthrombosis.



Development of a Novel Human CD147 Transgenic NSG Mouse Model to test SARS-CoV-2 Infection and Immune Responses



Molecular docking of secondary metabolites from Indonesian marine and terrestrial organisms targeting SARS-CoV-2 ACE-2, M pro, and PL pro receptors



Quinoline and Quinazoline Alkaloids against COVID-19: An In Silico Multitarget Approach



SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: An in silico drug repurposing study



Kobophenol A Inhibits Binding of Host ACE2 Receptor with Spike RBD Domain of SARS-CoV-2, a Lead Compound for Blocking COVID-19



E484K mutation in SARS-CoV-2 RBD enhances binding affinity with hACE2 but reduces interactions with neutralizing antibodies and nanobodies: Binding free energy calculation studies



Insights of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) pandemic: a current review



A glycan gate controls opening of the SARS-CoV-2 spike protein



Structural Dissection of Viral Spike-Protein Binding of SARS-CoV-2 and SARS-CoV-1 to the Human Angiotensin-Converting Enzyme 2 (ACE2) as Cellular Receptor



ACE2-targeting monoclonal antibody as potent and broad-spectrum coronavirus blocker



Identification of potent human neutralizing antibodies against SARS-CoV-2 implications for development of therapeutics and prophylactics



Natural variants in SARS-CoV-2 S protein pinpoint structural and functional hotspots: implications for prophylaxis and therapeutic strategies



SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target



Battling against the Coronavirus Disease 2019



SARS-CoV-2 in the sweat of COVID-19 positive patients: a possible route of transmission?



Spike mutation T403R allows bat coronavirus RaTG13 to use human ACE2



A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques



Membrane-Mediated Sars-cov-2 Host Cell Entry: Potential Inhibitory Roles of Terpenoids in Silico



Intermolecular Interaction Analyses on SARS-CoV-2 Receptor Binding Domain and Human Angiotensin-Converting Enzyme 2 Receptor-Blocking Antibody/peptide Using Fragment Molecular Orbital Calculation



In vitro screening of herbal medicinal products for their supportive curing potential in the context of SARS-CoV-2



A surrogate virus neutralization test to quantify antibody-mediated inhibition of SARS-CoV-2 in finger stick dried blood spot samples



TMPRSS11D and TMPRSS13 Activate the SARS-CoV-2 Spike Protein



E484K mutation in SARS-CoV-2 RBD enhances binding affinity with hACE2 but reduces interactions with neutralizing antibodies and nanobodies: Binding free energy calculation studies


More Human Angiotensin Converting sentence examples
10.1016/j.compbiomed.2021.104759

Computational screening of 645 antiviral peptides against the receptor-binding domain of the spike protein in SARS-CoV-2



Pomegranate Peel Extract as an Inhibitor of SARS-CoV-2 Spike Binding to Human ACE2 Receptor (in vitro): A Promising Source of Novel Antiviral Drugs



Discovery of a Natural Product with Potent Efficacy Against SARS-CoV-2 by Drug Screening



Comparative genetic analyses of Korean bat coronaviruses with SARS-CoV and the newly emerged SARS-CoV-2



A time series forecasting of the proportion of SARS-CoV-2 N501Y lineage in North America



Molecular docking and dynamics studies of Nicotinamide Riboside as a potential multi-target nutraceutical against SARS-CoV-2 entry, replication, and transcription: A new insight



Possible impact of plasma oxidation on the structure of the C-terminal domain of SARS-CoV-2 spike protein: a computational study



SARS-CoV-2 Spike Pseudoviruses: A Useful Tool to Study Virus Entry and Address Emerging Neutralization Escape Phenotypes



Structural basis for SARS-CoV-2 neutralizing antibodies with novel binding epitopes



Inhibitory efficiency of potential drugs against SARS-CoV-2 by blocking human angiotensin converting enzyme-2: Virtual screening and molecular dynamics study



Minute-scale detection of SARS-CoV-2 using a low-cost biosensor composed of pencil graphite electrodes



Serine 477 plays a crucial role in the interaction of the SARS-CoV-2 spike protein with the human receptor ACE2



An ultrapotent neutralizing bispecific antibody with broad spectrum against SARS-CoV-2 variants



Molecular Dynamics Simulation Study of the Interaction between Human Angiotensin Converting Enzyme 2 and Spike Protein Receptor Binding Domain of the SARS-CoV-2 B.1.617 Variant



SARS-CoV-2 host cell entry: an in silico investigation of potential inhibitory roles of terpenoids



Designing Short Peptides to Block the Interaction of SARS-CoV-2 and Human ACE2 for COVID-19 Therapeutics



Non-competitive interactions between hydroxychloroquine and azithromycin: Systematic density functional, molecular dynamics, and docking calculations



Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice



Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model



The interferon-stimulated exosomal hACE2 potently inhibits SARS-CoV-2 replication through competitively blocking the virus entry


Learn more from Human Angiotensin Converting


Human Angiotensin Converting
Encyclopedia